Sort
21,453 grants matching “tuberculosis”
The Genome Analysis Core
$2,424,710Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
Bronchiectasis and chronic airway infection
$2,423,956Kevin Fennelly · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Optimization Of HIV Specific Immune Responses In Vivo
$2,423,669Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Resistance to MTB infection in HIV infected individuals in Uganda and S. Africa
$2,422,204W. Henry Henry Boom · Case Western Reserve University · R01 · FY2018 · AI
DEVELOPMENT OF UM-1098: A NOVEL SYNTHETIC TH17 INDUCING ADJUVANT AND DELIVERY SYSTEM
$2,419,904Jay Evans · University Of Montana · N01 · FY2023 · AI
Establishment of a SPF Rhesus Macaque Colony
$2,417,980Deepak Kaushal · Texas Biomedical Research Institute · U42 · FY2024 · OD
Establishment of a SPF Rhesus Macaque Colony
$2,417,980Deepak Kaushal · Texas Biomedical Research Institute · U42 · FY2023 · OD
Establishment of a SPF Rhesus Macaque Colony
$2,417,980Deepak Kaushal · Texas Biomedical Research Institute · U42 · FY2025 · OD
Human MAIT celis in airway mucosal immune responses to intracellular infections
$2,416,430David M. Lewinsohn · Oregon Health & Science University · U01 · FY2012 · AI
East Africa IeDEA Regional Consortium
$2,416,231Kara Kay Wools-Kaloustian · Indiana University Indianapolis · U01 · FY2012 · AI
Role of inflammation, innate resistance, and immunity in carcinogenesis.
$2,415,233Giorgio Trinchieri · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Safety Evaluation of Anti-Infective Agents
$2,414,000Jon Carl Mirsalis · Sri International · N01 · FY2013 · AI
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)
$2,408,741Payam Nahid · University Of California, San Francisco · R01 · FY2025 · AI
The UCSD CD4 Collaborative Clinical Trial Unit
$2,407,704Constance Ann Benson · University Of California, San Diego · UM1 · FY2016 · AI
Structure-based Discovery of Critical Vulnerabilities of Mycobacteria
$2,407,325James C Sacchettini · Texas A&M Agrilife Research · P01 · FY2021 · AI
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
$2,405,177Michael David Hughes · Harvard School Of Public Health · UM1 · FY2021 · AI
Bronchiectasis and chronic airway infection
$2,404,445Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
PHRU-Setshaba Clinical Trials Unit
$2,404,119Glenda E Gray · Wits Health Consortium (Pty), Ltd · UM1 · FY2023 · AI
Knockdown of Gene Expression in Immune Cells in Humanized Mice
$2,404,025Judy Lieberman · Immune Disease Institute, Inc. · RC4 · FY2010 · AI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit
$2,403,962Jeffrey Lennox · Emory University · UM1 · FY2017 · AI
Discovery of Chemical Probes and Therapeutic Leads, Phase II
$2,399,995Joseph M Fox · University Of Delaware · P20 · FY2023 · GM
Discovery of Chemical Probes and Therapeutic Leads, Phase II
$2,399,995Joseph M Fox · University Of Delaware · P20 · FY2024 · GM
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis
$2,399,184Jerrold J. Ellner · Rbhs-New Jersey Medical School · U19 · FY2018 · AI
Epidemiology and transmission dynamics of MDR/XDR tuberculosis
$2,399,034Megan B Murray · Brigham And Women'S Hospital · U19 · FY2011 · AI
Tulane National Primate Research Center
$2,396,052Lee Hamm · Tulane University Of Louisiana · P51 · FY2023 · OD